Titan Medical Inc. (TMDIF)
USD 0.82
(2173.99%)
USD 0.82
(2173.99%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 4.76 Million | -26.48 Million | -36.29 Million | -889.76 Thousand | -47.02 Million | -39.28 Million |
| Net Income | 7.08 Million | -40.85 Million | -14.72 Million | -25.46 Million | -42.88 Million | -21.48 Million |
| Depreciation & Amortization | 189.41 Thousand | 825.92 Thousand | 692.84 Thousand | 249.35 Thousand | 33.31 Thousand | 27.55 Thousand |
| Deferred income taxes | - | -53.78 Thousand | 55.5 Thousand | - | - | - |
| Stock-based compensation | 996 Thousand | 4.08 Million | 4.03 Million | 1.09 Million | - | - |
| Change in working capital | -3.75 Million | 11.7 Million | -10.44 Million | -5.17 Million | 13.61 Million | -2.16 Million |
| Other non-cash items | 4.97 Million | -5.73 Million | -1.62 Million | 30.57 Million | -26.25 Million | -9.43 Million |
| Investing Cash Flow | 24.44 Thousand | -979.58 Thousand | -748.35 Thousand | -631.03 Thousand | -468.68 Thousand | -399.13 Thousand |
| Investments in PPE | -216.9 Thousand | -979.58 Thousand | -748.35 Thousand | -631.03 Thousand | -468.68 Thousand | -399.13 Thousand |
| Acquisitions | 241.34 Thousand | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 24 Thousand | - | - | - | - | - |
| Financing Cash Flow | -459.27 Thousand | -402.39 Thousand | 43.82 Million | 27.47 Million | 36.59 Million | 25.77 Million |
| Debt repayment | -451 Thousand | -421 Thousand | -306.28 Thousand | -1.57 Million | -5218.57 | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 1920.75 | 43.78 Million | 25.99 Million | 36.59 Million | 25.77 Million |
| Other Financing Activities | -459.27 Thousand | - | - | - | - | - |
| Accounts receivables | -102.85 Thousand | 7.95 Million | -9.93 Million | -573.18 Thousand | 8.53 Million | -6.17 Million |
| Accounts payables | -3.24 Million | 1.32 Million | 1.07 Million | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -404.28 Thousand | 2.43 Million | -1.58 Million | -4.6 Million | 5.08 Million | 4.01 Million |
| Cash at beginning of period | 3.28 Million | 32.26 Million | 25.46 Million | 814.49 Thousand | 11.47 Million | 26.13 Million |
| Cash at end of period | 7.5 Million | 3.28 Million | 32.26 Million | 25.46 Million | 814.49 Thousand | 11.47 Million |
| Capital Expenditure | -216.9 Thousand | -979.58 Thousand | -748.35 Thousand | -631.03 Thousand | -468.68 Thousand | -399.13 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 4.21 Million | -28.97 Million | 6.79 Million | 24.65 Million | -10.65 Million | -14.65 Million |
| Free Cash Flow | 4.54 Million | -27.46 Million | -37.04 Million | -1.52 Million | -47.49 Million | -39.68 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.06 Million | -803.39 Thousand | -3.33 Million | 7.08 Million | 67.13 Thousand | 12.86 Million |
| Depreciation & Amortization | - | - | 89.4 Thousand | 189.41 Thousand | 32.58 Thousand | 32.42 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 6000.00 | -190 Thousand | -26 Thousand | 996 Thousand | 224 Thousand | 622 Thousand |
| Change in working capital | -628.74 Thousand | -724.74 Thousand | 754.43 Thousand | -3.75 Million | -1.39 Million | -3.76 Million |
| Other non-cash items | 930.25 Thousand | 870.09 Thousand | 455.74 Thousand | 4.97 Million | 1.53 Million | 2.79 Million |
| Investing Cash Flow | - | - | -570.05 Thousand | 24.44 Thousand | 180.17 Thousand | 466.9 Thousand |
| Investments in PPE | - | - | -62.43 Thousand | -216.9 Thousand | -54.46 Thousand | -41.48 Thousand |
| Acquisitions | - | - | 498.27 | 241.34 Thousand | 234.97 Thousand | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | -508.11 Thousand | - | -332.37 | 508.39 Thousand |
| Financing Cash Flow | -146 Thousand | -145.34 Thousand | -149.31 Thousand | -459.27 Thousand | -140.67 Thousand | -85.12 Thousand |
| Debt repayment | -146 Thousand | -146 Thousand | -146 Thousand | -451 Thousand | -142 Thousand | -84 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | 15.99 Thousand | 14.93 Thousand | 360.55 Thousand | -102.85 Thousand | -452.1 Thousand | - |
| Accounts payables | -915.95 Thousand | -1.03 Million | 1.2 Million | -3.24 Million | -1.47 Million | -2.72 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | 271.22 Thousand | 299.65 Thousand | -836.23 Thousand | -404.28 Thousand | 530.51 Thousand | -1.03 Million |
| Cash at beginning of period | 5.7 Million | 7.5 Million | 8.85 Million | 3.28 Million | 10.6 Million | 1.26 Million |
| Cash at end of period | 3.89 Million | 5.7 Million | 7.5 Million | 7.5 Million | 8.85 Million | 10.6 Million |
| Capital Expenditure | - | - | -62.43 Thousand | -216.9 Thousand | -54.46 Thousand | -41.48 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -1.8 Million | -1.8 Million | -1.34 Million | 4.21 Million | -1.75 Million | 9.33 Million |
| Free Cash Flow | -1.66 Million | -1.68 Million | -708.06 Thousand | 4.54 Million | -1.81 Million | 9.09 Million |
HLFDF
CAP
SMR
BH-A
NXFNF
6548